ArticleHIV medicine2025

Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort.

Andrea De Vito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.